Javascript Error

Your browser JavaScript is turned off causing certain features of the NIAID Institute of Allergy and Infectious Diseases web site to work incorrectly. Please visit your browser settings and turn JavaScript on.
Read more information on enabling JavaScript.

Awards to U.S. Institutions. Awards to U.S. institutions for research involving select agents will contain a Term of Award requiring registration with the Centers for Disease Control and Prevention (CDC) of HHS or Animal and Plant Health Inspection Service (APHIS) of USDA, depending on the agent, prior to using NIH funds for such research.

Awards to non-U.S. (Foreign) Institutions. Awards to non-U.S. institutions for research involving select agents will contain a Term of Award requiring U.S. review and approval of safety and security measures and practices prior to use of NIH funds for such research. An NIH-chaired committee of U.S. federal employees (including representatives of NIH grants and scientific program management, CDC, Department of Justice and other federal intelligence agencies, and Department of State) will assess the policies and procedures for comparability to the U.S. requirements described in 42 CFR Part 73.

Toward this end, awardee institutions must be willing to provide key information delineating any laws, regulations, policies, and procedures applicable to the institution for the safe and secure possession, use, and transfer of select agents. This includes concise summaries of safety, security, and training plans, and applicable laws, regulations, and policies.

For security risk assessments, awardee institutions must be willing to provide the names of all individuals who will have access to the select agents and procedures for ensuring that only approved and appropriate individuals have access to select agents that are the subject of the NIH award.

Awards to U.S. Institutions with Foreign Components. Awards to U.S. institutions with non-U.S. components for research involving select agents will contain a Term of Award (or a Special Contract Requirements Clause under Section H in the case of contract awards) requiring U.S. review and approval of safety and security measures and practices prior to use of NIH funds for such research.

An NIH-chaired committee of U.S. federal employees (including representatives of NIH grants and scientific program management, CDC, Department of Justice and other federal intelligence agencies, and Department of State) will assess the policies and procedures for comparability to the U.S. requirements described in the National Select Agent Registry Regulations.

Toward this end, the U.S. awardee institution must be willing to provide key information delineating any laws, regulations, policies, and procedures applicable to the foreign institution for the safe and secure possession, use, and transfer of select agents. This includes concise summaries of safety, security, and training plans, and applicable laws, regulations and policies.

For security risk assessments, awardee institutions must be willing to provide the names of all individuals at the foreign institution who will have access to the select agents and procedures for ensuring that only approved/appropriate individuals have access to select agents that are the subject of the NIH award.